Bradley Foster & Sargent Inc. CT lessened its holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 67.3% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 92,284 shares of the pharmacy operator’s stock after selling 189,902 shares during the quarter. Bradley Foster & Sargent Inc. CT’s holdings in Walgreens Boots Alliance were worth $7,227,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also modified their holdings of the stock. Hudock Capital Group LLC raised its holdings in Walgreens Boots Alliance by 0.5% during the 2nd quarter. Hudock Capital Group LLC now owns 1,306 shares of the pharmacy operator’s stock worth $102,000 after purchasing an additional 6 shares during the last quarter. Reilly Financial Advisors LLC raised its holdings in Walgreens Boots Alliance by 7.9% during the 2nd quarter. Reilly Financial Advisors LLC now owns 1,367 shares of the pharmacy operator’s stock worth $107,000 after purchasing an additional 100 shares during the last quarter. Orrstown Financial Services Inc. raised its holdings in Walgreens Boots Alliance by 14.1% during the 2nd quarter. Orrstown Financial Services Inc. now owns 1,728 shares of the pharmacy operator’s stock worth $135,000 after purchasing an additional 213 shares during the last quarter. Founders Capital Management bought a new position in Walgreens Boots Alliance during the 1st quarter worth approximately $161,000. Finally, Hanson McClain Inc. raised its holdings in Walgreens Boots Alliance by 4.6% during the 2nd quarter. Hanson McClain Inc. now owns 1,987 shares of the pharmacy operator’s stock worth $156,000 after purchasing an additional 87 shares during the last quarter. Institutional investors and hedge funds own 60.24% of the company’s stock.
Several research analysts have issued reports on the stock. Needham & Company LLC set a $94.00 price target on shares of Walgreens Boots Alliance and gave the stock a “buy” rating in a report on Monday, July 17th. Loop Capital set a $90.00 price target on shares of Walgreens Boots Alliance and gave the stock a “buy” rating in a report on Thursday, October 26th. Zacks Investment Research upgraded shares of Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a report on Monday. BidaskClub upgraded shares of Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a report on Wednesday, August 30th. Finally, Royal Bank Of Canada assumed coverage on shares of Walgreens Boots Alliance in a report on Tuesday, September 19th. They set an “outperform” rating and a $96.00 price target for the company. One analyst has rated the stock with a sell rating, seven have issued a hold rating and fifteen have issued a buy rating to the company. The company presently has a consensus rating of “Buy” and an average price target of $88.00.
Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) opened at 66.27 on Wednesday. The company has a 50-day moving average of $73.66 and a 200 day moving average of $79.30. The firm has a market cap of $70.92 billion, a P/E ratio of 16.73 and a beta of 1.25. Walgreens Boots Alliance, Inc. has a 52-week low of $63.82 and a 52-week high of $88.00.
Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings data on Wednesday, October 25th. The pharmacy operator reported $1.31 EPS for the quarter, beating the consensus estimate of $1.21 by $0.10. Walgreens Boots Alliance had a return on equity of 18.36% and a net margin of 3.45%. The company had revenue of $30.15 billion for the quarter, compared to analysts’ expectations of $29.93 billion. During the same period last year, the firm posted $1.07 earnings per share. Walgreens Boots Alliance’s revenue was up 5.3% compared to the same quarter last year. On average, equities analysts expect that Walgreens Boots Alliance, Inc. will post $5.50 earnings per share for the current year.
Walgreens Boots Alliance declared that its board has authorized a share repurchase plan on Wednesday, October 25th that permits the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization permits the pharmacy operator to reacquire shares of its stock through open market purchases. Shares repurchase plans are typically an indication that the company’s board believes its shares are undervalued.
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 12th. Investors of record on Monday, November 13th will be given a dividend of $0.40 per share. The ex-dividend date of this dividend is Friday, November 10th. This represents a $1.60 annualized dividend and a dividend yield of 2.41%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is presently 42.33%.
In other Walgreens Boots Alliance news, Director John Anthony Lederer acquired 20,000 shares of the company’s stock in a transaction that occurred on Thursday, October 26th. The shares were bought at an average cost of $67.00 per share, with a total value of $1,340,000.00. Following the completion of the transaction, the director now directly owns 50,000 shares of the company’s stock, valued at approximately $3,350,000. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 13.50% of the company’s stock.
ILLEGAL ACTIVITY NOTICE: This news story was posted by Community Financial News and is the sole property of of Community Financial News. If you are reading this news story on another publication, it was illegally copied and reposted in violation of U.S. and international copyright and trademark law. The legal version of this news story can be read at https://www.com-unik.info/2017/11/01/bradley-foster-sargent-inc-ct-reduces-position-in-walgreens-boots-alliance-inc-wba.html.
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA).
What are top analysts saying about Walgreens Boots Alliance Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Walgreens Boots Alliance Inc. and related companies.